9IFX | pdb_00009ifx

Beta-hairpin macrocyclic peptide in complex with STAT1


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.64 Å
  • R-Value Free: 
    0.271 (Depositor), 0.264 (DCC) 
  • R-Value Work: 
    0.229 (Depositor), 0.226 (DCC) 
  • R-Value Observed: 
    0.231 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history


Literature

Consequences of Peptide Macrocyclization Revealed by Virus-Inspired beta-Hairpin Mimetics.

Bula, A.L.Bobrovs, R.Arsenyan, P.Pantelejevs, T.

(2026) ACS Chem Biol 21: 160-169

  • DOI: https://doi.org/10.1021/acschembio.5c00834
  • Primary Citation of Related Structures:  
    9IFX, 9IGA

  • PubMed Abstract: 

    Mimicry of protein secondary structure elements, such as α-helices and β-sheets, using conformationally constrained peptide macrocycles, can be utilized to disrupt native protein-protein and protein-nucleic acid interactions. Although α-helical stapled peptides have been extensively studied as pharmacological probes, the application of β-sheet and β-hairpin mimetics remains comparatively limited. Less is known about the structural and biophysical consequences of β-hairpin macrocyclization in the context of target binding. In this work, we use a poxvirus immune antagonist protein 018 as a template for the structure-based design of β-hairpin mimetic macrocyclic peptides targeting the STAT1 transcription factor. We demonstrate that successive orthogonal cyclizations have additive effects on the thermodynamic and kinetic properties of peptide binding, most notably slowing the dissociation from the target. We elucidate the structural and dynamic consequences of interstrand and head-to-tail cross-linking and propose a kinetic model explaining the gains in target residence. Finally, we highlight the pharmacological potential of these peptides by competitive inhibition of STAT1 binding to its cognate interferon receptor docking site. These data suggest that β-hairpin macrocyclization may represent a general strategy to extend target engagement, with implications for peptidic probe design.


  • Organizational Affiliation
    • Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Signal transducer and activator of transcription 1-alpha/beta545Homo sapiensMutation(s): 3 
Gene Names: STAT1
UniProt & NIH Common Fund Data Resources
Find proteins for P42224 (Homo sapiens)
Explore P42224 
Go to UniProtKB:  P42224
PHAROS:  P42224
GTEx:  ENSG00000115415 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP42224
Sequence Annotations
Expand
  • Reference Sequence

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
OPG024 proteinB [auth C]21Orthopoxvirus vacciniaMutation(s): 3 
UniProt
Find proteins for P17356 (Vaccinia virus (strain Western Reserve))
Explore P17356 
Go to UniProtKB:  P17356
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP17356
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
OXE (Subject of Investigation/LOI)
Query on OXE

Download Ideal Coordinates CCD File 
C
ORTHO-XYLENE
C8 H10
CTQNGGLPUBDAKN-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.64 Å
  • R-Value Free:  0.271 (Depositor), 0.264 (DCC) 
  • R-Value Work:  0.229 (Depositor), 0.226 (DCC) 
  • R-Value Observed: 0.231 (Depositor) 
Space Group: P 42
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 161.135α = 90
b = 161.135β = 90
c = 38.478γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
autoPROCdata reduction
autoPROCdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
European Union (EU)European UnionRRF grant No.01/OSI/PA RRF project No. 5.2.1.1.i.0/2/24/I/CFLA/001

Revision History  (Full details and data files)

  • Version 1.0: 2026-02-18
    Type: Initial release